Five Star Equities Provides Stock Research on Halozyme Therapeutics and Novavax
Continue ReadingTag: research-reports
ECB Leaves Interest Rate at Record Low 0.75% – Euro Zone Could See Growth Return in 2014
RDInvesting Provides Stock Research on Bank of Ireland and Royal Bank of Scotland Group
Continue ReadingBlue Chip Garnering Increased Attention as Dow Hits Record High
RDINvesting Provides Stock Research on 3M and United Technologies
Continue ReadingECB and Bank of England Leaves Interest Rates Unchanged – Euro Zone Economy Expected to Start Stabilizing in Second Half of 2013
RDInvesting Provides Stock Research on Deutsche Bank and HSBC
Continue ReadingFDA Programs Designed to Speed Up Approval Process Helps Send Drug Approvals to a 15-Year High in 2012
Five Star Equities Provides Stock Research on Aegerion Pharmaceuticals and Alnylam
Continue ReadingFDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing
Five Star Equities Provides Stock Research on Idenix Pharmaceuticals and Peregrine Pharmaceuticals
Continue ReadingDow Jones Industrial Average Reach Record High – Dividend Payments From Dow 30 Not Far Behind
RDINvesting Provides Stock Research on AT&T and Microsoft
Continue ReadingDividends From the Dow 30 Reach Highest Level Since Before the Financial Crisis
RDINvesting Provides Stock Research on Du Pont and The Home Depot
Continue ReadingPrograms by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech-s Industry Success
Five Star Equities Provides Stock Research on Galena Biopharma and Keryx Biopharmaceuticals
Continue ReadingBiotech Industry Looks to Benefit From FDA-s New “Breakthrough” Designation
Five Star Equities Provides Stock Research on Dendreon and MannKind
Continue Reading